These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8010998)

  • 1. Linear pharmacokinetics of a new inotropic agent.
    Trenque T; Barre J; Lamiable D; Tillement JP
    Arzneimittelforschung; 1994 Apr; 44(4):471-3. PubMed ID: 8010998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 1st Communication: balance of elimination, plasma and blood kinetics, metabolism in rats.
    Tufenkji AE; Campistron G; Malbosc R; Declume C; Dormard Y; Atabakhsh F; Benard P; Houin G
    Arzneimittelforschung; 1993 Mar; 43(3):323-6. PubMed ID: 8489560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 2nd communication: tissue distribution in rats.
    Atabakhsh F; Benard P; Declume C; Tufenkji AE; Malbosc R; Campistron G; Houin G
    Arzneimittelforschung; 1993 Apr; 43(4):436-40. PubMed ID: 8494573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 3rd communication: whole-body autoradiographic study in Cynomolgus monkeys after oral administration.
    Benard P; Dormard Y; Houin G; Declume C; Malbosc R; Tufenkji AE; Galtier P; Alvinerie M
    Arzneimittelforschung; 1993 May; 43(5):516-20. PubMed ID: 8328994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
    Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
    Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and biotransformation of 3-cyan-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in the rat].
    Vagaday M; Kunter U; Labes D; Hagen V; Böhme B; Franke P
    Pharmazie; 1994 Jan; 49(1):41-7. PubMed ID: 8140129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS; Bae SK; Lee MG
    Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration.
    Farré M; Roset PN; Llorente M; Márquez M; Albet C; Pérez JA; Herrero E; Ortíz JA
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):343-50. PubMed ID: 9379783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals.
    Sundberg S; Antila S; Scheinin H; Häyhä M; Virtanen M; Lehtonen L
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):629-35. PubMed ID: 9876999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of disulfiram-mediated CYP2E1 inhibition on the disposition of vesnarinone.
    Frye RF; Tammara B; Cowart TD; Bramer SL
    J Clin Pharmacol; 1999 Nov; 39(11):1177-83. PubMed ID: 10579149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations.
    Snoeck E; Piotrovskij V; Jacqmin P; Lins RL; Van Peer A; Danhof M; Woestenborghs R; Van Gool R; Dupont AG; Heykants J
    Eur J Clin Pharmacol; 1997; 53(1):57-63. PubMed ID: 9349931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humans.
    Asai F; Jakubowski JA; Naganuma H; Brandt JT; Matsushima N; Hirota T; Freestone S; Winters KJ
    Platelets; 2006 Jun; 17(4):209-17. PubMed ID: 16769598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of higenamine in rabbits.
    Lo CF; Chen CM
    Biopharm Drug Dispos; 1996 Dec; 17(9):791-803. PubMed ID: 8968531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administration.
    Plusquellec Y; Barre J; de Biasi J; Trenque T; Tillement JP; Houin G
    J Pharm Sci; 1992 Oct; 81(10):1020-3. PubMed ID: 1432613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
    Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
    J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.